201. アンジェルマン症候群 Angelman syndrome Clinical trials / Disease details

臨床試験数 : 25 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-003787-48-NL (EUCTR)	22/09/2020	08/10/2020	Angelman syndrome is a complex genetic disorder that primarily affects the nervous system.	AN OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARM ...	Angelman Syndrome MedDRA version: 20.0;Level: PT;Classification code 10049004;Term: Angelman's syndr ...	Product Code: RO7248824 /F02-01 INN or Proposed INN: Not available Other descriptive name: RO7248824 Pro ...	F. Hoffmann-La Roche	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	66	Phase 1	United States;Canada;Spain;Netherlands;United Kingdom;Italy
2	EUCTR2019-003787-48-GB (EUCTR)	11/06/2020	16/03/2020	Angelman syndrome is a complex genetic disorder that primarily affects the nervous system.	AN OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARM ...	Angelman Syndrome MedDRA version: 20.0;Level: PT;Classification code 10049004;Term: Angelman's syndr ...	Product Code: RO7248824 /F02-01 INN or Proposed INN: Not available Other descriptive name: RO7248824 Pro ...	F. Hoffmann-La Roche	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	66	Phase 1	United States;Canada;Spain;Netherlands;Italy;United Kingdom

First Previous1Next Last